Skip to main content
Premium Trial:

Request an Annual Quote

QB3 Teams with Deloitte on Strategic Planning

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – The California Institute for Quantitative Biosciences (QB3), a public-private partnership focused on life sciences development, has turned to consulting and financial services firm Deloitte to help with its strategic planning, policy, and project management efforts.

The institute, which includes private industry partners and more than 200 scientists at three San Francisco Bay area universities, will work with Deloitte's life science consultants to plan an "innovation ecosystem" to bring together academic research, government, industry, and investor partners, Deloitte and the University of California, San Francisco said Monday.

"The California economy and life sciences industry seem to be caught in an almost desperate search for creative new approaches," QB3 Director Regis Kelly said in a statement. "We see the 'innovation ecosystem' project as the start of an ongoing effort with Deloitte to generate the kind of creative solutions that are needed now and into the future."

The institute's university partners include UCSF and the University of California campuses at Berkeley and Santa Cruz.

Deloitte will provide analysis, planning, and management services that QB3 will use to develop its relationships with government, universities, investors, and bioscience companies in an effort to move investments and innovation from the lab to the market more swiftly. The partners plan to focus on these four stakeholder communities because they can work together to "unclog the pipeline" that takes scientific innovation into patient care, Kelly added.

"The problems in life sciences cannot be solved without the key players working together, not only from the private and public sector, but also from university researchers who are the starting point for innovative breakthroughs," Matthew Hudes, Deloitte's US leader for biotechnology, said in the statement.

"Our goal is to develop a model for an innovation ecosystem that enables those breakthroughs to improve human health worldwide," Hudes said.

Deloitte also said that it plans to work with QB3 to launch a program of bioscience industry awards and speaker forums to recognize innovators and entrepreneurs, and to provide a platform for networking and education.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.